{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:44:45Z","timestamp":1790372685393,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD100607"],"award-info":[{"award-number":["R01HD100607"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.expneurol.2025.115171","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T21:23:40Z","timestamp":1738185820000},"page":"115171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Early postnatal GABAB antagonist treatment normalizes inhibitory\/excitatory balance in neonatal Ts65Dn mice, a genetic model of down syndrome"],"prefix":"10.1016","volume":"386","author":[{"given":"Joshua","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Kleschevnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2025.115171_bb0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrg.2016.154","article-title":"Down syndrome and the complexity of genome dosage imbalance","volume":"18","author":"Antonarakis","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.expneurol.2025.115171_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.770359","article-title":"Structural characterization of the highly restricted down syndrome critical region on 21q22.13: new KCNJ6 and DSCR4 transcript isoforms","volume":"12","author":"Antonaros","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71085-9","article-title":"Impairment of spatial memory accuracy improved by Cbr1 copy number resumption and GABAB receptor-dependent enhancement of synaptic inhibition in down syndrome model mice","volume":"10","author":"Arima-Yoshida","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115171_bb0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbagrm.2007.09.005","article-title":"Analysis of the promoter region of human placenta-specific DSCR4 gene","volume":"1779","author":"Asai","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2025.115171_bb0030","article-title":"Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1\/Yey mouse models of down syndrome","volume":"11","author":"Aziz","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.expneurol.2025.115171_bb0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/revneuro-2022-0067","article-title":"Brain circuit pathology in down syndrome: from neurons to neural networks","volume":"34","author":"Bartesaghi","year":"2023","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0040","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/ajmg.a.32975","article-title":"Keppen-Lubinsky syndrome: expanding the phenotype","volume":"149A","author":"Basel-Vanagaite","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.expneurol.2025.115171_bb0045","first-page":"83","article-title":"Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat","volume":"14","author":"Bayer","year":"1993","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2025.115171_bb0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.410200413","article-title":"Dendritic atrophy in children with Down\u2019s syndrome","volume":"20","author":"Becker","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cne.20337","article-title":"Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome","volume":"480","author":"Belichenko","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cne.21433","article-title":"Synaptic and cognitive abnormalities in mouse models of down syndrome: exploring genotype-phenotype relationships","volume":"504","author":"Belichenko","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0065","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1523\/JNEUROSCI.1547-09.2009","article-title":"The \u201cdown syndrome critical region\u201d is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of down syndrome","volume":"29","author":"Belichenko","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0070","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/cne.21895","article-title":"Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of down syndrome","volume":"512","author":"Belichenko","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134861","article-title":"Down syndrome cognitive phenotypes modeled in mice Trisomic for all HSA 21 homologues","volume":"10","author":"Belichenko","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2025.115171_bb0080","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1152\/physrev.00017.2006","article-title":"GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations","volume":"87","author":"Ben-Ari","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.expneurol.2025.115171_bb0085","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1152\/jn.00626.2006","article-title":"Ts65Dn, a mouse model of down syndrome, exhibits increased GABAB-induced potassium current","volume":"97","author":"Best","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0090","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.expneurol.2011.11.033","article-title":"Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of down syndrome","volume":"233","author":"Best","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0095","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1523\/JNEUROSCI.0534-10.2010","article-title":"Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for down syndrome","volume":"30","author":"Bianchi","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0100","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/epi.13034","article-title":"The GIRK2 subunit is involved in IS-like seizures induced by GABA(B) receptor agonists","volume":"56","author":"Blichowski","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2025.115171_bb0105","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1073\/pnas.90.7.2955","article-title":"Localization of a retroviral element within the rd gene coding for the beta subunit of cGMP phosphodiesterase","volume":"90","author":"Bowes","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2025.115171_bb0110","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1177\/0269881111405366","article-title":"Specific targeting of the GABA-A receptor alpha5 subtype by a selective inverse agonist restores cognitive deficits in down syndrome mice","volume":"25","author":"Braudeau","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009777","article-title":"Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and down syndrome","volume":"17","author":"Brault","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0120","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nn.2600","article-title":"Olig1 and Olig2 triplication causes developmental brain defects in down syndrome","volume":"13","author":"Chakrabarti","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0006-8993(97)00896-2","article-title":"Developmental expression of the GIRK family of inward rectifying potassium channels: implications for abnormalities in the weaver mutant mouse","volume":"778","author":"Chen","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2025.115171_bb0130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/hipo.20308","article-title":"Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with down syndrome and in Ts65Dn mice","volume":"17","author":"Contestabile","year":"2007","journal-title":"Hippocampus"},{"key":"10.1016\/j.expneurol.2025.115171_bb0135","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1073\/pnas.1109099109","article-title":"Trisomy of the G protein-coupled K+ channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice","volume":"109","author":"Cooper","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2025.115171_bb0140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1203\/PDR.0b013e31819d9076","article-title":"Infantile spasms and down syndrome: a new animal model","volume":"65","author":"Cortez","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.expneurol.2025.115171_bb0145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neulet.2005.03.031","article-title":"Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of down syndrome","volume":"382","author":"Costa","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2025.115171_bb0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1054-3589(10)58015-3","article-title":"GABAB-GIRK2-mediated signaling in down syndrome","volume":"58","author":"Cramer","year":"2010","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0155","first-page":"117","article-title":"Segmental trisomy as a mouse model for down syndrome","volume":"384","author":"Davisson","year":"1993","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.expneurol.2025.115171_bb0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2017.10.002","article-title":"GABAergic over-inhibition, a promising hypothesis for cognitive deficits in down syndrome","volume":"114","author":"de San","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2025.115171_bb0165","article-title":"Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of down syndrome","volume":"9","author":"de San","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2025.115171_bb0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/pd.2684","article-title":"Hypomethylated DSCR4 is a placenta-derived epigenetic marker for trisomy 21","volume":"31","author":"Du","year":"2011","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.expneurol.2025.115171_bb0175","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00335-011-9356-0","article-title":"Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome","volume":"22","author":"Duchon","year":"2011","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.expneurol.2025.115171_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104874","article-title":"Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of down syndrome","volume":"140","author":"Emili","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115171_bb0185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tins.2007.07.005","article-title":"Over-inhibition: a model for developmental intellectual disability","volume":"30","author":"Fernandez","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nn1860","article-title":"Pharmacotherapy for cognitive impairment in a mouse model of down syndrome","volume":"10","author":"Fernandez","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0195","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1460-9568.2011.07886.x","article-title":"Developmental regulation of G protein-gated inwardly-rectifying K+ (GIRK\/Kir3) channel subunits in the brain","volume":"34","author":"Fernandez-Alacid","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0200","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/BF00294247","article-title":"Down\u2019s syndrome and Alzheimer\u2019s disease: dendritic spine counts in the hippocampus","volume":"79","author":"Ferrer","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0205","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrn3249","article-title":"Regulation of neuronal GABA(B) receptor functions by subunit composition","volume":"13","author":"Gassmann","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0210","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1523\/JNEUROSCI.2513-15.2016","article-title":"Absence of prenatal forebrain defects in the Dp(16)1Yey\/+ mouse model of down syndrome","volume":"36","author":"Goodliffe","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0215","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/ajmg.a.37156","article-title":"The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of down syndrome","volume":"167A","author":"Guedj","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.expneurol.2025.115171_bb0220","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1750-3639.2007.00113.x","article-title":"Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with down syndrome","volume":"18","author":"Guidi","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0225","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/bpa.12605","article-title":"Abnormal development of the inferior temporal region in fetuses with down syndrome","volume":"28","author":"Guidi","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078561","article-title":"Alterations to dendritic spine morphology, but not dendrite patterning, of cortical projection neurons in Tc1 and Ts1Rhr mouse models of down syndrome","volume":"8","author":"Haas","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2025.115171_bb0235","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/cne.20844","article-title":"Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of down syndrome","volume":"494","author":"Harashima","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.877711","article-title":"Developmental neuropathology and neurodegeneration of down syndrome: current knowledge in humans","volume":"10","author":"Hasina","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0245","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tins.2011.11.001","article-title":"Trisomy 21 and early brain development","volume":"35","author":"Haydar","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0250","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1093\/hmg\/ddv364","article-title":"Genetic dissection of the down syndrome critical region","volume":"24","author":"Jiang","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0255","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ana.24749","article-title":"Infantile spasms in down syndrome: rescue by knockdown of the GIRK2 channel","volume":"80","author":"Joshi","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0260","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eplepsyres.2018.06.006","article-title":"Kcnj6(GIRK2) trisomy is not sufficient for conferring the susceptibility to infantile spasms seen in the Ts65Dn mouse model of down syndrome","volume":"145","author":"Joshi","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2025.115171_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.941855","article-title":"Neurodevelopment in down syndrome: concordance in humans and models","volume":"16","author":"Klein","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115171_bb0270","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/1567205020666221223122110","article-title":"GIRK2 Channels in Down Syndrome and Alzheimer's Disease","volume":"19","author":"Kleschevnikov","year":"2022","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.expneurol.2025.115171_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1006068","article-title":"Enhanced GIRK2 channel signaling in down syndrome: a feasible role in the development of abnormal nascent neural circuits","volume":"13","author":"Kleschevnikov","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0280","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1523\/JNEUROSCI.1766-04.2004","article-title":"Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of down syndrome","volume":"24","author":"Kleschevnikov","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0285","series-title":"Program no. 115.7. Abstract Viewer\/Itinerary Planner. Washington, DC: Society for Neuroscience","article-title":"Expression of GIRK2 and related proteins after chronic administrations of Prozac in Ts65Dn mice, a genetic model of down syndrome","author":"Kleschevnikov","year":"2005"},{"key":"10.1016\/j.expneurol.2025.115171_bb0290","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1523\/JNEUROSCI.1673-12.2012","article-title":"Deficits in cognition and synaptic plasticity in a mouse model of down syndrome ameliorated by GABAB receptor antagonists","volume":"32","author":"Kleschevnikov","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0295","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.nbd.2011.10.009","article-title":"Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of down syndrome","volume":"45","author":"Kleschevnikov","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115171_bb0300","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-444-54299-1.00010-8","article-title":"Discoveries in down syndrome: moving basic science to clinical care","volume":"197","author":"Kleschevnikov","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2025.115171_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2017.03.009","article-title":"Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of down syndrome","volume":"103","author":"Kleschevnikov","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115171_bb0310","first-page":"236","article-title":"Molecular definition of a region of chromosome 21 that causes features of the down syndrome phenotype","volume":"47","author":"Korenberg","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0315","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.aanat.2008.05.007","article-title":"Reduced cell number in the neocortical part of the human fetal brain in down syndrome","volume":"190","author":"Larsen","year":"2008","journal-title":"Ann. Anat."},{"key":"10.1016\/j.expneurol.2025.115171_bb0320","first-page":"1721","article-title":"Study of somatic chromosomes from 9 mongoloid children","volume":"248","author":"Lejeune","year":"1959","journal-title":"C. R. Hebd. Seances Acad. Sci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0325","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1523\/JNEUROSCI.16-22-07137.1996","article-title":"Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain","volume":"16","author":"Liao","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002078","article-title":"DSCAM gene triplication causes excessive GABAergic synapses in the neocortex in down syndrome mouse models","volume":"21","author":"Liu","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0335","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0006-8993(72)90324-1","article-title":"Structural abnormalities of the cerebral cortex in human chromosomal aberrations: a Golgi study","volume":"44","author":"Marin-Padilla","year":"1972","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2025.115171_bb0340","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cne.901670105","article-title":"Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study","volume":"167","author":"Marin-Padilla","year":"1976","journal-title":"J. Comp. Neurol."},{"issue":"Pt 2","key":"10.1016\/j.expneurol.2025.115171_bb0345","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neubiorev.2013.12.008","article-title":"Treating enhanced GABAergic inhibition in down syndrome: use of GABA alpha5-selective inverse agonists","volume":"46","author":"Martinez-Cue","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"Pt 2","key":"10.1016\/j.expneurol.2025.115171_bb0350","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neubiorev.2013.12.008","article-title":"Treating enhanced GABAergic inhibition in down syndrome: use of GABA alpha5-selective inverse agonists","volume":"46","author":"Martinez-Cue","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2025.115171_bb0355","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ajhg.2014.12.011","article-title":"Keppen-Lubinsky syndrome is caused by mutations in the inwardly rectifying K+ channel encoded by KCNJ6","volume":"96","author":"Masotti","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0360","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0888-7543(89)90065-7","article-title":"Molecular genetic approach to the characterization of the \u201cdown syndrome region\u201d of chromosome 21","volume":"5","author":"McCormick","year":"1989","journal-title":"Genomics"},{"key":"10.1016\/j.expneurol.2025.115171_bb0365","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/hipo.22664","article-title":"GABAergic hyperinnervation of dentate granule cells in the Ts65Dn mouse model of down syndrome: exploring the role of app","volume":"26","author":"Mojabi","year":"2016","journal-title":"Hippocampus"},{"key":"10.1016\/j.expneurol.2025.115171_bb0370","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.expneurol.2016.02.005","article-title":"Longitudinal measures of cognition in the Ts65Dn mouse: refining windows and defining modalities for therapeutic intervention in down syndrome","volume":"279","author":"Olmos-Serrano","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0375","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/hmg\/ddm022","article-title":"Trisomy for the down syndrome \u2018critical region\u2019 is necessary but not sufficient for brain phenotypes of trisomic mice","volume":"16","author":"Olson","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0380","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1460-9568.2002.02111.x","article-title":"Degeneration of pontine mossy fibres during cerebellar development in weaver mutant mice","volume":"16","author":"Ozaki","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0385","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ng1095-126","article-title":"A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation","volume":"11","author":"Patil","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.102139","article-title":"Early alterations in cortical and cerebellar regional brain growth in down syndrome: an in vivo fetal and neonatal MRI assessment","volume":"25","author":"Patkee","year":"2020","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.expneurol.2025.115171_bb0395","first-page":"2525","article-title":"Systematic reanalysis of partial trisomy 21 cases with or without down syndrome suggests a small region on 21q22.13 as critical to the phenotype","volume":"25","author":"Pelleri","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.797","article-title":"Partial trisomy 21 map: ten cases further supporting the highly restricted down syndrome critical region (HR-DSCR) on human chromosome 21","volume":"7","author":"Pelleri","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.expneurol.2025.115171_bb0405","first-page":"266","article-title":"Partial trisomy 21 with or without highly restricted down syndrome critical region (HR-DSCR): report of two new cases and reanalysis of the genotype-phenotype association","volume":"15","author":"Pelleri","year":"2022","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0410","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/hmg\/3.10.1735","article-title":"A transcript map of the down syndrome critical region on chromosome 21","volume":"3","author":"Peterson","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115171_bb0415","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4826","article-title":"Intraperitoneal injection of neonatal mice","volume":"13","author":"Pocratsky","year":"2023","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.expneurol.2025.115171_bb0420","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/cne.22573","article-title":"Three-dimensional synaptic ultrastructure in the dentate gyrus and hippocampal area CA3 in the Ts65Dn mouse model of down syndrome","volume":"519","author":"Popov","year":"2011","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0425","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/18715273113126660185","article-title":"Reducing GABAergic inhibition restores cognitive functions in a mouse model of down syndrome","volume":"13","author":"Potier","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.expneurol.2025.115171_bb0430","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/18715273113126660185","article-title":"Reducing GABAergic inhibition restores cognitive functions in a mouse model of down syndrome","volume":"13","author":"Potier","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.expneurol.2025.115171_bb0435","first-page":"141","article-title":"Normal and aberrant neuronal development in the cerebral cortex of human fetus and young infant","author":"Purpura","year":"1975","journal-title":"UCLA Forum Med. Sci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036082","article-title":"Effects of neonatal neural progenitor cell implantation on adult neuroanatomy and cognition in the Ts65Dn model of down syndrome","volume":"7","author":"Rachubinski","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2025.115171_bb0445","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-0-12-804766-8.00017-0","article-title":"Down syndrome","volume":"167","author":"Rafii","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0450","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31543","article-title":"Alterations of in vivo CA1 network activity in Dp(16)1Yey down syndrome model mice","volume":"7","author":"Raveau","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2025.115171_bb0455","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2017.06.017","article-title":"Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of down syndrome","volume":"106","author":"Roncace","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115171_bb0460","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/7854_2020_129","article-title":"Mechanisms and regulation of neuronal GABAB receptor-dependent signaling","volume":"52","author":"Rose","year":"2022","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1266\/ggs.20-00012","article-title":"Possible roles for the hominoid-specific DSCR4 gene in human cells","volume":"96","author":"Saber","year":"2021","journal-title":"Genes Genet. Syst."},{"key":"10.1016\/j.expneurol.2025.115171_bb0470","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0006-8993(95)00974-U","article-title":"Morphological abnormalities in the hippocampus of the weaver mutant mouse","volume":"696","author":"Sekiguchi","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2025.115171_bb0475","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2005.02.012","article-title":"Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of down syndrome","volume":"49","author":"Siarey","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2025.115171_bb0480","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nbd.2014.04.016","article-title":"Excitation\/inhibition balance and learning are modified by Dyrk1a gene dosage","volume":"69","author":"Souchet","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115171_bb0485","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fnbeh.2015.00267","article-title":"Pharmacological correction of excitation\/inhibition imbalance in down syndrome mouse models","volume":"9","author":"Souchet","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0490","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fnbeh.2015.00265","article-title":"Timing of therapies for down syndrome: the sooner, the better","volume":"9","author":"Stagni","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0495","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nbd.2014.12.005","article-title":"Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice","volume":"74","author":"Stagni","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115171_bb0500","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2019.05.005","article-title":"Neonatal treatment with cyclosporine a restores neurogenesis and spinogenesis in the Ts65Dn model of down syndrome","volume":"129","author":"Stagni","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115171_bb0505","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ebiom.2015.07.038","article-title":"Involvement of potassium and cation channels in hippocampal abnormalities of embryonic Ts65Dn and Tc1 Trisomic mice","volume":"2","author":"Stern","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.expneurol.2025.115171_bb0510","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-444-54299-1.00005-4","article-title":"Pathways to cognitive deficits in down syndrome","volume":"197","author":"Sturgeon","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2025.115171_bb0515","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00688755","article-title":"Spine distribution along the apical dendrites of the pyramidal neurons in Down's syndrome. A quantitative Golgi study","volume":"50","author":"Suetsugu","year":"1980","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2025.115171_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(81)90314-0","article-title":"Abnormal neuronal development in the visual cortex of the human fetus and infant with down\u2019s syndrome. A quantitative and qualitative Golgi study","volume":"225","author":"Takashima","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2025.115171_bb0525","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0387-7604(89)80082-8","article-title":"Dendrites, dementia and the down syndrome","volume":"11","author":"Takashima","year":"1989","journal-title":"Brain and Development"},{"key":"10.1016\/j.expneurol.2025.115171_bb0530","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/cercor\/bhz094","article-title":"Quantitative MRI analyses of regional brain growth in living fetuses with down syndrome","volume":"30","author":"Tarui","year":"2020","journal-title":"Cereb. Cortex"},{"issue":"52","key":"10.1016\/j.expneurol.2025.115171_bb0535","first-page":"54","article-title":"Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT)","volume":"29","author":"Truett","year":"2000","journal-title":"Biotechniques"},{"key":"10.1016\/j.expneurol.2025.115171_bb0540","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hipo.23303","article-title":"Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of down syndrome","volume":"31","author":"Uguagliati","year":"2021","journal-title":"Hippocampus"},{"key":"10.1016\/j.expneurol.2025.115171_bb0545","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1038\/s41467-019-13004-9","article-title":"Unbalanced dendritic inhibition of CA1 neurons drives spatial-memory deficits in the Ts2Cje down syndrome model","volume":"10","author":"Valbuena","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2025.115171_bb0550","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/1028415X.2020.1861897","article-title":"Early postnatal oleic acid administration enhances synaptic development and cognitive abilities in the Ts65Dn mouse model of down syndrome","volume":"25","author":"Vidal","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0555","doi-asserted-by":"crossref","first-page":"e1465","DOI":"10.1542\/peds.2006-3448","article-title":"Fetal down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development","volume":"120","author":"Whittle","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.expneurol.2025.115171_bb0560","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1523\/JNEUROSCI.5746-12.2013","article-title":"Modeling transformations of neurodevelopmental sequences across mammalian species","volume":"33","author":"Workman","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115171_bb0565","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajmg.a.33735","article-title":"Clinical manifestations of the deletion of down syndrome critical region including DYRK1A and KCNJ6","volume":"155A","author":"Yamamoto","year":"2011","journal-title":"Am. J. Med. Genet. A"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T19:55:29Z","timestamp":1740686129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":113,"alternative-id":["S0014488625000354"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115171","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early postnatal GABAB antagonist treatment normalizes inhibitory\/excitatory balance in neonatal Ts65Dn mice, a genetic model of down syndrome","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115171"}}